Showing results (401-410 of 593) with videos related to

Sort By:
Pageof 60
Psychological Services|October 1, 2020
Gender, psychiatric disability, and dropout from peer support specialist trainingJames K Cunningham, Jennifer Schultz De La Rosa, Cristian A Quinones, et al.
Journal of Primary Health Care|May 2, 2019
Research using electronic health records: Balancing confidentiality and public goodKatharine A Wallis, Kyle S Eggleton, Susan M Dovey, et al.
The Journal of Rheumatology|October 1, 1995
Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and EnglandH Subair, H Tiwana, M Fielder, et al.
Drug and Alcohol Dependence|November 7, 2012
Mexico's precursor chemical controls: emergence of less potent types of methamphetamine in the United StatesJames K Cunningham, Jane Carlisle Maxwell, Octavio Campollo, et al.
Addiction (Abingdon, England)|August 5, 2010
Proximity to the US-Mexico border: a key to explaining geographic variation in US methamphetamine, cocaine and heroin purityJames K Cunningham, Jane Carlisle Maxwell, Octavio Campollo, et al.
Drug and Alcohol Dependence|May 18, 2012
Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizuresJames K Cunningham, Russell C Callaghan, Daoqin Tong, et al.
Drug and Alcohol Dependence|December 6, 2011
Non-injection drug use and hepatitis C among drug treatment clients in west central MexicoOctavio Campollo, Sonia Roman, Arturo Panduro, et al.
British Journal of Psychology (London, England : 1953)|November 15, 2024
Automated face recognition assists with low-prevalence face identity mismatches but can bias usersMelina Mueller, Peter J B Hancock, Emily K Cunningham, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|April 21, 1998
The clinician-scientist in neuropsychiatry: a position statement from the Committee on Research of the American Neuropsychiatric AssociationJ L Cummings, C E Coffey, J D Duffy, et al.
European Journal of Haematology|April 1, 1995
The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalitiesR Carmel, P S Gott, C H Waters, et al.
Pageof 60